TipRanks on MSN
Radiopharm Theranostics’ RAD301 Study: A Potential Game-Changer in Cancer Diagnostics
Radiopharm Theranostics Limited (($AU:RAD)) announced an update on their ongoing clinical study. Radiopharm Theranostics Limited is conducting a ...
Among test types, Bone Marker Tests are projected to account for 27.5% of total market revenue in 2025, making them the ...
Biodesix announces expanded Bio-Rad Laboratories partnership agreement to develop Droplet Digital PCR high complexity assays: Louisville, Colorado Friday, October 24, 2025, 12:00 ...
Enduro21 tests all three 2026 Honda RedMoto enduro range models, straight from HQ in Italy – developed from the Honda CRF RX ...
Biodesix has expanded its collaboration with Bio-Rad for the development and clinical validation of in vitro diagnostic (IVD) ...
Investing.com -- Biodesix (NYSE:BDSX) stock rose 10% Wednesday after the diagnostics solutions company announced an expanded partnership agreement with Bio-Rad Laboratories to develop high complexity ...
Residual DNA Testing is vital in detecting trace DNA post-biological processes, crucial for safety across biotechnology, pharmaceuticals, and forensics. It ensures biopharmaceuticals like vaccines are ...
Electric Bike Explorer on MSN
Rad Power Bikes Radster Road Review 2025: Powerful, Safe & Smart Commuter E-Bike
The Radster Road marks a bold step forward for Rad Power Bikes. As the company’s first new model since 2022, this ...
GLEN ALLEN, Va. - Adial Pharmaceuticals, Inc. (NASDAQ:ADIL), currently trading at $0.40 with a market capitalization of $8.7 million, announced Thursday it has completed analytical validation of a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results